Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

Anti-allodynic and neuroprotective effects of koumine, a Benth alkaloid, in a rat model of diabetic neuropathy.

Ling Q, Liu M, Wu MX, Xu Y, Yang J, Huang HH, Yu CX.

Biol Pharm Bull. 2014;37(5):858-64.

2.

Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone.

Xu Y, Qiu HQ, Liu H, Liu M, Huang ZY, Yang J, Su YP, Yu CX.

Pharmacol Biochem Behav. 2012 May;101(3):504-14. doi: 10.1016/j.pbb.2012.02.009. Epub 2012 Feb 16.

PMID:
22366214
3.

Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions.

Visnagri A, Kandhare AD, Chakravarty S, Ghosh P, Bodhankar SL.

Pharm Biol. 2014 Jul;52(7):814-28. doi: 10.3109/13880209.2013.870584. Epub 2014 Feb 21.

PMID:
24559476
4.

Koumine enhances spinal cord 3╬▒-hydroxysteroid oxidoreductase expression and activity in a rat model of neuropathic pain.

Qiu HQ, Xu Y, Jin GL, Yang J, Liu M, Li SP, Yu CX.

Mol Pain. 2015 Aug 9;11:46. doi: 10.1186/s12990-015-0050-1.

5.

The neuroprotective effects of progesterone on experimental diabetic neuropathy in rats.

Sameni HR, Panahi M, Sarkaki A, Saki GH, Makvandi M.

Pak J Biol Sci. 2008 Aug 15;11(16):1994-2000.

PMID:
19266905
6.

Tanshinone IIA improves impaired nerve functions in experimental diabetic rats.

Liu Y, Wang L, Li X, Lv C, Feng D, Luo Z.

Biochem Biophys Res Commun. 2010 Aug 13;399(1):49-54. doi: 10.1016/j.bbrc.2010.07.037. Epub 2010 Jul 15.

PMID:
20637731
7.

Treatment with Actovegin® improves sensory nerve function and pathology in streptozotocin-diabetic rats via mechanisms involving inhibition of PARP activation.

Dieckmann A, Kriebel M, Andriambeloson E, Ziegler D, Elmlinger M.

Exp Clin Endocrinol Diabetes. 2012 Mar;120(3):132-8. doi: 10.1055/s-0031-1291248. Epub 2011 Oct 21.

PMID:
22020669
8.

Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.

Bordet T, Buisson B, Michaud M, Abitbol JL, Marchand F, Grist J, Andriambeloson E, Malcangio M, Pruss RM.

J Pharmacol Exp Ther. 2008 Aug;326(2):623-32. doi: 10.1124/jpet.108.139410. Epub 2008 May 20.

9.

Antinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.

Chen SR, Samoriski G, Pan HL.

Neuropharmacology. 2009 Aug;57(2):121-6. doi: 10.1016/j.neuropharm.2009.04.010. Epub 2009 May 5.

10.

Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats.

Attia HN, Al-Rasheed NM, Al-Rasheed NM, Maklad YA, Ahmed AA, Kenawy SA.

Behav Pharmacol. 2012 Apr;23(2):153-61. doi: 10.1097/FBP.0b013e3283512c00.

PMID:
22411174
11.

Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy: effects of gabapentin.

Morgado C, Terra PP, Tavares I.

Eur J Pain. 2010 Aug;14(7):693-9. doi: 10.1016/j.ejpain.2009.11.011. Epub 2009 Dec 28.

PMID:
20056558
12.

Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy.

Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL.

Fitoterapia. 2012 Jun;83(4):650-9. doi: 10.1016/j.fitote.2012.01.010. Epub 2012 Feb 9.

PMID:
22343014
13.

Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats.

Sugimoto K, Rashid IB, Shoji M, Suda T, Yasujima M.

J Pain. 2008 Mar;9(3):237-45. doi: 10.1016/j.jpain.2007.10.016. Epub 2007 Dec 3.

PMID:
18331706
14.

Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy.

Kumar A, Kaundal RK, Iyer S, Sharma SS.

Life Sci. 2007 Mar 6;80(13):1236-44. Epub 2007 Jan 20.

PMID:
17289084
15.

Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy.

Naruse K, Sato J, Funakubo M, Hata M, Nakamura N, Kobayashi Y, Kamiya H, Shibata T, Kondo M, Himeno T, Matsubara T, Oiso Y, Nakamura J.

PLoS One. 2011;6(11):e27458. doi: 10.1371/journal.pone.0027458. Epub 2011 Nov 18.

16.

Effect of lacidipine pre-treatment on diabetic neuropathy in rats.

Singh J, Aditya S, Lal H, Arora B.

Arch Physiol Biochem. 2011 Feb;117(1):12-7. doi: 10.3109/13813455.2010.525241. Epub 2010 Nov 22.

PMID:
21091185
17.

Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats.

Obrosova IG, Drel VR, Oltman CL, Mashtalir N, Tibrewala J, Groves JT, Yorek MA.

Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1645-55. Epub 2007 Oct 2.

18.

Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy.

Lindner MD, Bourin C, Chen P, McElroy JF, Leet JE, Hogan JB, Stock DA, Machet F.

Exp Clin Psychopharmacol. 2006 Feb;14(1):42-51.

PMID:
16503704
19.

ACTH4-9 analogue ORG 2766 can improve existing neuropathy in streptozocin-induced diabetic rats.

Bravenboer B, Kappelle AC, van Buren T, Erkelens DW, Gispen WH.

Acta Diabetol. 1993;30(1):21-4.

PMID:
8392402
20.

A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.

Drel VR, Pacher P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov VV, Tibrewala J, Groves JT, Obrosova IG.

Eur J Pharmacol. 2007 Aug 13;569(1-2):48-58. Epub 2007 Jun 9.

Items per page

Supplemental Content

Write to the Help Desk